Sleeve gastrectomy and gastric banding: Effects on plasma ghrelin levels

Obesity Surgery

Volumn 15, Issue 7, 2005, Pages 1024-1029

  Langer, F B ^a   Hoda, M A Reza ^a   Bohdjalian, A ^a   Felberbauer, F X ^a   Zacherl, J ^a   Wenzl, E ^a   Schindler, K ^a   Luger, A ^a   Ludvik, B ^a   Prager, Gerhard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Gastric banding; Ghrelin; Morbid obesity; Sleeve gastrectomy

Indexed keywords

GHRELIN;

ADULT; BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GASTRECTOMY; GASTRIC BANDING; HORMONE SYNTHESIS; HUMAN; LAPAROSCOPIC SURGERY; MALE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; ROUX Y ANASTOMOSIS; STOMACH FUNDUS; WEIGHT REDUCTION;

ADULT; FEMALE; GASTRECTOMY; GASTROPLASTY; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY, MORBID; PEPTIDE HORMONES; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 23644457942     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/0960892054621125     Document Type: Conference Paper

References (41)

1. Miller K, Hell E. Laparoscopic surgical concepts of morbid obesity. Langenbecks Arch Surg 2003; 388: 375-84.
2. Feng JJ, Gagner M. Laparoscopic biliopancreatic diversion with duodenal switch. Semin Laparosc Surg 2002; 9: 125-9.
3. Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 2000; 10: 514-23; discussion 24.
4. Marceau P, Hould FS, Simard S et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22: 947-54.
5. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y - 500 patients: technique and results, with 3-60 month follow-up. Obes Surg 2000; 10: 233-9.
6. Ceelen W, Walder J, Cardon A et al. Surgical treatment of severe obesity with a low-pressure adjustable gastric band: experimental data and clinical results in 625 patients. Ann Surg 2003; 237: 10-6.
7. Chevallier J-M, Zinzindohoué F, Douard R et al. Complications after adjustable gastric banding for morbid obesity: experience with 1,000 patients over 7 years. Obes Surg 2004; 14: 407-14.
8. Chapman AE, Kiroff G, Game P et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004; 135: 326-51.
9. Kojima M, Hosoda H, Date Y et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.
10. Ariyasu H, Takaya K, Tagami T et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001; 86: 4753-8.
11. Gnanapavan S, Kola B, Bustin SA et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988-94.
12. Wren AM, Small CJ, Ward HL et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000; 141: 4325-8.
13. Takaya K, Ariyasu H, Kanamoto N et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000; 85: 4908-11.
14. Peino R, Baldelli R, Rodriguez-Garcia J et al. Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol 2000; 143: R11-4.
15. Wren AM, Seal LJ, Cohen MA et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992-5.
16. Cummings DE, Purnell JQ, Frayo RS et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-9.
17. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-13.
18. Cummings DE, Weigle DS, Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-30.
19. Geloneze B, Tambascia MA, Pilla VF et al. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg 2003; 13: 17-22.
20. Tritos NA, Mun E, Bertkau A et al. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res 2003; 11: 919-24.
21. Faraj M, Havel PJ, Phelis S et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 1594-602.
22. Hanusch-Enserer U, Brabant G, Roden M. Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. N Engl J Med 2003; 348: 2159-60.
23. Adami GF, Cordera R, Marinari G et al. Plasma ghrelin concentration in the short-term following biliopancreatic diversion. Obes Surg 2003; 13: 889-92.
24. Johnston D, Dachtler J, Sue-Ling HM et al. The Magenstrasse and Mill operation for morbid obesity. Obes Surg 2003; 13: 10-6.
25. Carmichael AR, Sue-Ling HM, Johnston D. Quality of life after the Magenstrasse and Mill procedure for morbid obesity. Obes Surg 2001; 11: 708-15.
26. Regan JP, Inabnet WB, Gagner M et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 2003; 13: 861-4.
27. Miline L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI ≥50). Obes Surg 2005; 15: 612-7.
28. Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg 2004; 14: 492-7.
29. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Draft Statement. Obes Surg 1991; 1: 257-66.
30. Fielding GA, Allen JW. A step-by-step guide to placement of the Lap-Band adjustable gastric banding system. Am J Surg 2002;184:26S-30S.
31. Dargent J. Pouch dilatation and slippage after adjustable gastric banding: is it still an issue? Obes Surg 2003; 13: 111-5.
32. O'Brien PE, Dixon JB, Laurie D et al. A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg 2005; 15: 820-6.
33. Langer FB, Bohdjalian A, Hoda A et al. Early results of laparoscopic adjustable gastric banding using the new low-pressure Soft-Gastric-Band. Eur Surg 2004; 36: 345-9.
34. Klingler A. Statistical methods in surgical research - a practical guide. Eur Surg 2004; 36: 80-4.
35. Fruhbeck G, Rotellar F, Hernandez-Lizoain JL et al. Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia. Obes Surg 2004; 14: 1208-15.
36. Holdstock C, Engstrom BE, Ohrvall M et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003; 88: 3177-83.
37. Leonetti F, Silecchia G, Iacobellis G et al. Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab 2003; 88: 4227-31.
38. Schindler K, Prager G, Ballaban T et al. Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest 2004; 34: 549-54.
39. Stoeckli R, Chanda R, Langer I et al. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res 2004; 12: 346-50.
40. Nijhuis J, van Dielen FM, Buurman WA et al. Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study. Obes Surg 2004; 14: 783-7.
41. Gualillo O, Caminos J, Blanco M et al. Ghrelin, a novel placental-derived hormone. Endocrinology 2001; 142: 788-94.